Join life sciences and healthcare executives in research, portfolio delivery, market access, and registry design as they share perspectives in real-world evidence (RWE) design and utilization.

This discussion, facilitated by Slalom Global Life Sciences Industry Lead Johanna DeYoung, will include data and RWE considerations for regulatory acceleration, commercialization, post-market surveillance, and market access.

Panelists include:

• Carla Balch | Founder and CEO, Spesana
• Jason Crites | Chief Executive Officer and Chief Data Officer, Assurance Health Data
• Melissa Boneta Davis, PhD | Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine
• Peter Krein, PhD | SVP, Precision Medicine, Boundless Bio
• Joe Lennerz, MD, PhD, MSc | Chief Scientific Officer, BostonGene

Following the panel, there will be light bites, drinks, and an opportunity to network with your peers.

Attendees will:

• connect different parts of the clinical development to market delivery ecosystem for real utility of RWE
• understand design for more successful programs and accelerated regulatory approval
• predict program and portfolio needs for successful product launches and clinical uptake
• future-proof their organizations by using RWE

Date: May 30, 2024
Time: 6 p.m. to 8 p.m. Central Standard Time
Format: 1 hour of panel discussion followed by networking, light bites, and drinks
Location: Slalom Chicago Office - Aon Center | 200 E Randolph Street, Floor 37, Chicago, IL, 60601